Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juan Manuel Betancort is active.

Publication


Featured researches published by Juan Manuel Betancort.


Tetrahedron | 2002

Stereoselective synthesis of syn-2,7-disubstituted-4,5-oxepenes

David Díaz Díaz; Juan Manuel Betancort; Fernando R. Pinacho Crisóstomo; Tomás Martín; Víctor S. Martín

Abstract An efficient synthesis of the title compounds as pure enantiomers is reported. The method is based on the intramolecular trapping of a carbocation generated by acid treatment of exo -Co 2 (CO) 6 -propargyl alcohols by a stereochemically controlled secondary hydroxy group located in a suitable chain.


Bioorganic & Medicinal Chemistry Letters | 2009

Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors.

Amogh Boloor; Denise Hanway; Maria Joshi; David T. Winn; Gabriel Mendez; Marlena Walls; Ping Wei; Fuxin Qian; Xiaoli Zhang; Yuliang Zhang; Michael Hepperle; Xinqiang Li; David Alan Campbell; Juan Manuel Betancort

A new series of NS3/4A protease boronic acid inhibitors is described. The compounds show good biochemical potency and cellular activity. The peptidomimetic inhibitors were evaluated against proteases from different HCV genotypes and clinically relevant NS3/4A mutants. Compound 28 displayed subnanomolar to single digit nanomolar potencies in the enzymatic assays and an EC50 of 25 nM in the replicon cell-based assay.


Bioorganic & Medicinal Chemistry Letters | 2009

Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitors.

Juan Manuel Betancort; David T. Winn; Ruzhang Liu; Quansheng Xu; Junjuan Liu; Wensheng Liao; Shuhui Chen; David Carney; Denise Hanway; James Schmeits; Xinqiang Li; Eric M. Gordon; David Alan Campbell

The synthesis and biochemical evaluation of novel cyanothiazolidine inhibitors of dipeptidyl peptidase 4 (DPP4) is described. Their main structural feature is a constrained bicyclic core that prevents the intramolecular formation of inactive cyclic species. The inhibitors show good to moderate biochemical potency against DPP4 and display distinct selectivity profiles towards DPP7, DPP8 and DPP9 depending on their substitution.


Archive | 2004

Heterocyclic boronic acid compounds

David Alan Campbell; David T. Winn; Juan Manuel Betancort


Journal of Organic Chemistry | 1997

Stereocontrolled Synthesis of Cyclic Ethers by Intramolecular Hetero-Michael Addition. 5. Synthesis of All Diastereoisomers of 2,3,5,6-Tetrasubstituted Tetrahydropyrans

Juan Manuel Betancort; Víctor S. Martín; José M. Padrón; José M. Palazón; Miguel A. Ramírez; Marcos A. Soler


Archive | 2008

Macrocyclic hepatitis c protease inhibitors

David Alan Campbell; Michael Hepperle; David T. Winn; Juan Manuel Betancort


Archive | 2007

Hepatitis c serine protease inhibitors and uses therefor

David Alan Campbell; Michael Hepperle; David T. Winn; Juan Manuel Betancort


Archive | 2006

Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-iv

David Alan Campbell; David T. Winn; Juan Manuel Betancort


Archive | 2007

MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR

David Alan Campbell; Michael Hepperle; David T. Winn; Juan Manuel Betancort


Archive | 2007

N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain

David Alan Campbell; Michael Hepperle; David T. Winn; Juan Manuel Betancort

Collaboration


Dive into the Juan Manuel Betancort's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Díaz Díaz

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge